Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 54.86%312.52M | ---- | -19.69%201.8M | ---- | -71.79%251.28M | ---- | -27.05%890.65M | ---- | 10.27%1.22B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -4.86%-37.44M | ---- | 6.51%-35.71M | ---- | -35.92%-38.19M | ---- | 11.09%-28.1M | ---- | -15.49%-31.6M |
| Investment loss (gain) | ---- | -20.75%17.55M | ---- | 290.96%22.15M | ---- | -126.54%-11.6M | ---- | --43.69M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -284.02%-26.1M |
| Impairment and provisions: | ---- | -59.96%122.94M | ---- | -31.53%307.05M | ---- | 28.42%448.43M | ---- | 100.00%349.18M | ---- | 241.46%174.59M |
| -Impairment of property, plant and equipment (reversal) | ---- | -155.30%-13.88M | ---- | 382.77%25.1M | ---- | --5.2M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | -59.47%110.81M | ---- | 21.89%273.41M | ---- | -21.04%224.3M | ---- | 62.71%284.09M | ---- | 241.46%174.59M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | 1,019.79%162.01M | ---- | --14.47M | ---- | ---- |
| -Other impairments and provisions | ---- | 204.44%26.01M | ---- | -84.99%8.54M | ---- | 12.42%56.92M | ---- | --50.63M | ---- | ---- |
| Revaluation surplus: | ---- | -21.74%54K | ---- | 101.04%69K | ---- | -6,519.00%-6.62M | ---- | ---100K | ---- | ---- |
| -Other fair value changes | ---- | -21.74%54K | ---- | 101.04%69K | ---- | -6,519.00%-6.62M | ---- | ---100K | ---- | ---- |
| Asset sale loss (gain): | ---- | 282.18%5.96M | ---- | -60.45%1.56M | ---- | -79.68%3.94M | ---- | 166.36%19.41M | ---- | 19.97%7.29M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---1.95M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | --5.8M | ---- | ---- | ---- | -98.61%36K | ---- | 29.95%2.59M | ---- | -63.55%1.99M |
| -Loss (gain) from selling other assets | ---- | -89.42%165K | ---- | -73.37%1.56M | ---- | -65.18%5.86M | ---- | 217.72%16.82M | ---- | 773.60%5.29M |
| Depreciation and amortization: | ---- | 12.14%281.1M | ---- | -2.26%250.67M | ---- | -7.43%256.47M | ---- | 13.04%277.05M | ---- | 37.38%245.1M |
| -Amortization of intangible assets | ---- | 36.98%90.35M | ---- | -1.37%65.96M | ---- | 16.76%66.87M | ---- | 3.59%57.28M | ---- | 43.05%55.29M |
| Financial expense | ---- | -10.54%51.64M | ---- | 286.31%57.73M | ---- | -20.32%14.94M | ---- | -34.99%18.75M | ---- | -13.45%28.85M |
| Special items | ---- | ---- | ---- | ---- | ---- | -54.80%4.91M | ---- | -82.92%10.86M | ---- | 225.42%63.57M |
| Operating profit before the change of operating capital | ---- | -6.33%754.33M | ---- | -12.80%805.31M | ---- | -41.60%923.56M | ---- | -6.01%1.58B | ---- | 18.36%1.68B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 174.46%31.22M | ---- | 82.10%-41.93M | ---- | -9.02%-234.18M | ---- | 61.37%-214.8M | ---- | 0.69%-556.07M |
| Accounts receivable (increase)decrease | ---- | -128.13%-29.42M | ---- | 143.80%104.59M | ---- | -231.81%-238.76M | ---- | -66.67%-71.96M | ---- | 34.16%-43.17M |
| Accounts payable increase (decrease) | ---- | 55.24%-316.72M | ---- | -9.78%-707.65M | ---- | -1,000.60%-644.63M | ---- | -75.86%71.58M | ---- | -45.79%296.53M |
| prepayments (increase)decrease | ---- | -113.89%-26.58M | ---- | 1,676.89%191.29M | ---- | 75.52%-12.13M | ---- | -350.62%-49.55M | ---- | 110.49%19.77M |
| Derivative financial instruments (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 87.36%-386K |
| Cash from business operations | 50.15%356.17M | 17.41%412.83M | 168.08%237.21M | 270.58%351.62M | -7.82%-348.45M | -115.66%-206.13M | -230.20%-323.19M | -5.90%1.32B | -75.55%248.23M | 20.85%1.4B |
| China income tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 25.23%-116.89M | -45.52%-228.26M |
| Other taxs | -151.93%-51.05M | 42.47%-47.69M | 54.24%-20.26M | 53.21%-82.89M | 74.15%-44.28M | 32.10%-177.17M | -357.83%-171.28M | -362.03%-260.94M | -23.10%-37.41M | -25.22%-56.48M |
| Interest received - operating | -51.71%10.14M | -26.95%29.15M | 57.70%20.99M | -1.99%39.91M | -10.75%13.31M | 40.38%40.71M | 3.10%14.92M | 2.11%29M | 9.34%14.47M | -1.30%28.41M |
| Interest paid - operating | -23.47%-38.29M | -13.10%-94.92M | -137.71%-31.01M | -461.61%-83.92M | -36.91%-13.05M | -11.38%-14.94M | -14.01%-9.53M | -6.02%-13.42M | 28.42%-8.36M | 8.56%-12.65M |
| Net cash from operations | 33.85%276.97M | 33.23%299.37M | 152.72%206.93M | 162.85%224.71M | 19.75%-392.47M | -133.37%-357.54M | -588.92%-489.09M | -5.21%1.07B | -87.95%100.03M | 16.42%1.13B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | ---- | ---- | --12.62M | --12.46M | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | -2,600.00%-540M | -832.47%-381.11M | ---20M | ---40.87M | ---- | ---- | 244.70%133.92M | -123.45%-43.18M | -27.93%38.85M | 481.85%184.09M |
| Sale of fixed assets | -71.44%4.58M | 125.07%30.73M | 3,302.12%16.02M | 18.97%13.65M | 2.39%471K | --11.48M | 46.03%460K | ---- | -96.01%315K | ---- |
| Purchase of fixed assets | -0.05%-124.57M | 43.07%-347.27M | 58.29%-124.5M | -6.73%-609.97M | -39.69%-298.5M | -29.21%-571.51M | -29.68%-213.69M | -0.55%-442.32M | 16.19%-164.78M | -111.10%-439.89M |
| Selling intangible assets | ---- | --2.28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | -47.25%-29.79M | 48.11%-38.43M | 37.46%-20.23M | 44.33%-74.05M | 69.09%-32.34M | -16.62%-133.03M | -48.09%-104.63M | -70.92%-114.08M | -227.76%-70.65M | -34.34%-66.74M |
| Sale of subsidiaries | ---- | ---- | ---- | 1,918.56%111.02M | --111.02M | --5.5M | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | -880.40%-165.37M | ---- | --21.19M | --21.19M | ---- | ---- | ---- | ---- | -2,774.89%-80.04M |
| Recovery of cash from investments | ---- | 2,717.70%28.18M | -96.63%28.18M | --1M | --836.96M | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | 83.95%-28.18M | 99.19%-8.18M | -381.95%-175.51M | -796.12%-1.01B | -420.23%-36.42M | -1,513.21%-112.93M | ---7M | ---7M | ---- |
| Net cash from investment operations | -435.94%-689.78M | -21.36%-899.17M | 64.32%-128.7M | -2.34%-740.92M | -21.50%-360.68M | -19.36%-723.98M | -46.05%-296.87M | -50.67%-606.57M | 14.94%-203.27M | 9.57%-402.58M |
| Net cash before financing | -627.74%-412.81M | -16.19%-599.79M | 110.39%78.22M | 52.27%-516.21M | 4.17%-753.15M | -332.71%-1.08B | -661.32%-785.95M | -36.13%464.75M | -117.47%-103.24M | 38.44%727.64M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 324.47%1.12B | -62.17%926.8M | -87.92%263.62M | 189.24%2.45B | 781.28%2.18B | -17.11%847.08M | -41.64%247.54M | 284.39%1.02B | 543.57%424.15M | -39.40%265.85M |
| Refund | -568.92%-908.85M | 33.94%-1.07B | 88.37%-135.87M | -207.16%-1.62B | -366.53%-1.17B | 14.19%-528.78M | 11.40%-250.5M | -86.71%-616.21M | -86.67%-282.73M | 8.92%-330.04M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | 3,429.41%739.02M | 4,536.58%739.02M | 43.26%20.94M | 19.35%15.94M | -59.18%14.62M |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -4.50%-2.97M | 16.92%-8.1M |
| Dividends paid - financing | -24.86%-101.06M | 20.91%-81.92M | 20.94%-80.94M | 75.97%-103.58M | 76.25%-102.37M | -11.06%-431.1M | -11.06%-430.98M | -11.09%-388.16M | -11.61%-388.07M | -67.54%-349.41M |
| Absorb investment income | ---- | --13.53M | --13.53M | ---- | ---- | -71.61%1.8M | ---- | --6.34M | --6.25M | ---- |
| Issuance expenses and redemption of securities expenses | ---2.47M | ---980K | ---- | ---- | ---- | ---36.4M | ---- | ---- | ---- | ---- |
| Other items of the financing business | 104.69%152K | -176.30%-32.15M | -114.58%-3.24M | -67.58%42.14M | --22.25M | 1,323.54%129.99M | ---- | ---10.62M | ---10.62M | ---- |
| Net cash from financing operations | 75.91%91.47M | -140.09%-273.59M | -94.38%52M | 2.76%682.45M | 239.42%924.55M | 2,048.27%664.11M | 199.78%272.39M | 93.11%-34.09M | 41.24%-272.99M | -94.46%-494.87M |
| Effect of rate | 196.43%51.71M | 431.65%50.48M | -13.87%17.44M | -44.42%9.5M | 28.95%20.25M | 165.73%17.09M | 129.99%15.71M | 47.80%-25.99M | -215.57%-52.37M | -7.21%-49.8M |
| Net Cash | -346.76%-321.33M | -625.35%-873.38M | -24.02%130.22M | 139.83%166.25M | 133.37%171.4M | -196.92%-417.41M | -36.51%-513.56M | 85.01%430.67M | -397.62%-376.22M | -14.15%232.78M |
| Begining period cash | -40.39%1.21B | 9.44%2.04B | 9.44%2.04B | -17.70%1.86B | -17.70%1.86B | 21.79%2.26B | 21.79%2.26B | 10.93%1.86B | 10.93%1.86B | 15.50%1.67B |
| Cash at the end | -56.75%945.08M | -40.39%1.21B | 6.42%2.19B | 9.44%2.04B | 16.39%2.05B | -17.70%1.86B | 23.47%1.76B | 21.79%2.26B | -22.61%1.43B | 10.93%1.86B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -9.75%1.3B |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -9.75%1.3B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.